Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Operating Leases (2019 - 2025)

INVO Fertility (IVF) has disclosed Operating Leases for 7 consecutive years, with $2.0 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 11.8% to $2.0 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.0 million, a 11.8% decrease, with the full-year FY2024 number at $2.2 million, down 34.76% from a year prior.
  • Operating Leases was $2.0 million for Q3 2025 at INVO Fertility, down from $2.1 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $3.4 million in Q3 2023 to a low of $52789.0 in Q1 2021.
  • A 5-year average of $1.8 million and a median of $2.0 million in 2025 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: soared 2683.59% in 2022, then plummeted 34.76% in 2024.
  • INVO Fertility's Operating Leases stood at $1.5 million in 2021, then fell by 10.62% to $1.3 million in 2022, then soared by 149.08% to $3.4 million in 2023, then plummeted by 34.76% to $2.2 million in 2024, then fell by 9.25% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Operating Leases are $2.0 million (Q3 2025), $2.1 million (Q2 2025), and $2.1 million (Q1 2025).